Cathie Wood called this one of her most underappreciated stocks. Its CEO explains its growth story

By | March 15, 2021
0 Comment
Invitae CEO Sean George told CNBC he believes genetic testing will be central to health-care decisions in five to 10 years.

Related posts:

  1. Fed raises its economic outlook slightly, sees 4.2% growth next year and 5% unemployment rate
  2. Leon Cooperman says stock market could be stuck for years — ‘too much debt is being created’
  3. Christmas tree sales are telling a holly, jolly economic story
  4. Cramer says investors will regret selling U.S. stocks on coronavirus spikes in Europe
  5. Cramer says a Biden presidency with a GOP Senate would be ‘so boring’ — and that’s great for stocks
  6. ‘Get long’ — Cramer sees coronavirus trends driving stocks higher no matter who wins election
  7. UK House Price Growth Hits 6-Year High
  8. SpaceX prepares for Air Force test connecting an aircraft to its Starlink satellite internet
  9. The Supplement War — Which Players Are Dominating The Market?
  10. Cramer downplays market drop on Trump’s coronavirus, says investors should ready a buy list